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Dendritic cells (DCs) are potent antigen-presenting cells that play a central role in
immunity.
1 DC capture and process antigen are efficient and adept at stimulating
T cells and NK cells. The level of maturation is an important element of DC
function. Immature DCs are efficient at capturing antigen while they are relatively
poor at presenting antigen to T cells. Conversely, mature DC do not capture
antigen as well but potently-stimulated T cells. Maturation is a terminal and
critical event in DC development. DC require maturation before exhibiting their
full immuno-stimulatory and antitumor potential. 
It has been shown that 4-1BBL is expressed on mature B cells, macrophages,
and dendritic cells.
2 4-1BBL is a member of the tumor necrosis factor (TNF)
superfamily of type II membrane protein. 4-1BBL with its receptor 4-1BB
expressed on T interaction provided a co-stimulatory signal to T cells, including
activation of both CD4
+ and CD8
+ T cells, enhanced expansion,
3,4 increased long-
term survival,
5,6 and anti-apoptosis of activation-induced CD8
+ T cells.
7 Co-
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Purpose: The purpose of this study is to construct a recombinant adenovirus
vector carrying mouse 4-1BBL and observe its effects in dendritic cells. Materials
and Methods: Mouse 4-1BBL cDNA was taken from the plasmid pcDNA3-m4-
1BBL and subcloned into adenovirus shuttle plasmid pAdTrack-CMV, and then
transformed into competent BJ5183 with plasmid pAdEasy-1. After recombination
in E. coli, Ad-4-1BBL was packaged and amplified in HEK 293 cells. The expres-
sion of 4-1BBL in Ad-4-1BBL-transfected mouse prostate cancer cell line RM-1
was detected by reverse transcription polymerase chain reaction (RT-PCR) and
Western blot. After the co-culture of dendritic cells (DCs) with Ad-4-1BBL-
transfected RM-1 cells, interleukin (IL)-6 and IL-12 production were assessed by
enzyme-linked immunosorbent assay (ELISA) and co-stimulatary moleculs
(CD80 and CD86) on DCs were analyzed by flow cytometry. Results: The levels
of IL-6 (3,960 pg/mL) and IL-12 (249 pg/mL) production in Ad-m4-1BBL-pulsed
DCs were more than those in none-pulsed DCs. The differences were statistically
significant (p < 0.05). The expression of co-stimulatary molecules (CD80 and
CD86) was up-regulated in Ad-m4-1BBL-pulsed DCs. Conclusion: The results
indicated the recombinant mouse 4-1BBL can effectively activate DCs.
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INTRODUCTIONstimulation through 4-1BBL/4-1BB can also promote
enhanced production of cytokines such as interleukin (IL)-
2, IL-4, and interferon (IFN)-λ .
3,8 Futagawa, et al.
9 have
shown that immature DC expressed 4-1BBL at a high
level and the 4-1BB-4-1BBL interaction represent a novel
pathway of DC activation by DC-DC interaction. 
To further characterize the function of 4-1BBL in DC
activation, we used replication-deficient E1a-E1b/E3 dele-
tion mutant adenovirus sero-type 5 to yield the adenovirus-
4-1BBL (Ad-4-1BBL), and detected the change of immu-
noactivity of dendritic cells induced by Ad-m4-1BBL.
Animals and cell lines
Female C57BL/6 (H-2 K
b) mice, 6-8 wk old, were obtained
from Shanghai Slac Laboratory Animal Co. Ltd (Shanghai,
China). Animals were maintained at the Central Animal
Facility of Wuhan University according to standard guide-
lines and experiments were conducted according to the
guidelines of the China Council for Animal Care. RM-1, a
murine prostate cancer cell line, was obtained from the
Chinese Academy of Sciences (Shanghai, China). HEK
293, human embryonic kidney 293 cell line, was provided
by the Ministry of Education Key Laboratory of Virologyo
(Wuhan, China). All cells were cultured in RPMI-1640
medium with 10% fatal calf serum (FCS), 2 mM L-gluta-
mine, 100 U/mL penicillin, and 100 µg/mL streptomycin
at 37˚C in a humidified atmosphere containing 5% CO2.
Virus construction, identification and purification
The E1 and E3 regions deficient serotype 5 recombinant
adenovirus vector was used to construct Ad-m4-1BBL us-
ing pAdEasy-1 system gifted by the Ministry of Education
Key Laboratory of Virologyo (Wuhan, China). Briefly, the
murine 4-1BBL gene was amplified from plasmid pcDNA3-
m4-1BBL gifted by Dr. Tania Watts (Department of Im-
munology, University of Toronto, Canada). The amplified
DNA fragment was inserted into the shuttle vector pAdT-
rack-CMV in the BglII/HindIII-restriction sites. The resul-
tant plasmid was linearized by PmeI and subsequently co-
transformed into E. coli BJ5183 with a adenoviral backbone
plasmid (pAdEasy-1). Then the recombinant adenoviral
plasmid (pAd-m4-1BBL) was transfected into HEK 293
cells by Lipofectamine
TM 2000 (Invitrogen, Carlsbad, CA,
USA) for amplification. Adenovirus was purified by cen-
trifugation in a cesium chloride gradient. The Ad-eGFP
was constructed similarly using for control Ad virus.
Reverse transcription (RT)-PCR analysis
RM-1 cells (1×10
6) were infected with Ad-4-1BBL [mul-
tiplicity of infection (MOI) 50]. Two days later, cells were
collected and total ribonucleic acid (RNA) was extracted
using the Trizol agent. One microgram of total RNA was
used as a template for complementary DNA (cDNA) syn-
thesis using random primers and River Tra Ace according
to the manufacturer’s instructions. Following amplification
by polymerase chain reaction (PCR), the cycling condi-
tions are as follows: predegeneration at 94˚C for 5 min,
denaturation at 94˚C for 30s, annealing at 55˚C for 30s,
and extension at 72˚C for 45s for tPSMA (30 cycles), 4-
1BBL (30 cycles), and β-Actin (25 cycles). 4-1BBL for-
ward primer F was: 5’-TGTTCGCCAAGCTACTG-3’,
reverse primer R was: 5’-ATGGGTTGTCGGGTTTCA-
3’, β-actin forward primer F was: 5’-TCATGAAGT
GTGACGTGGACATC-3’, and reverse primer R was: 5’-
CAGGAGGAGCAATGATCTTGATCT-3’. After am-
plification, the PCR products were resolved by 1.2% aga-
rose gel electrophoresis.
Western blot analysis
RM-1 cells (1×10
6) were infected with the Ad-m4-1BBL
for 24 h, scraped and lysed. The lysates were separated on
10% sodium dodecyl sulfate-polyacrylamide gel electro-
phoress (SDS-PAGE). After electrophoresis, the protein
blots were transferred to a nitrocellulose membrane (Amer-
sham, Waukesha, WI, USA). The membrane was blocked
with 5% non-fat milk in TBST for 1 h and incubated over-
night with rabbit anti-4-1BBL polyclonal Ab at 4˚C. After
three washes with TBST, the membrane was incubated at
37˚C for 1 h with horseradish peroxidase-conjugated goat
anti-rabbit immunoglobulin G (IgG) secondary antibody
diluted with TBST (1 : 1000). The detected protein signals
were visualized by an enhanced chemilluminescence reac-
tion system. Western blot for β-Actin was used as an inter-
nal sample.
DCs generation and coculture with Ad-4-1BBL 
transfected RM-1 cells
Mouse DCs were generated from bone marrow suspen-
sions harvested from 6-8 week old C57BL/6 mice accord-
ing to the publication
10 with slight modifications. Briefly,
bone-marrow cells were harvested from femurs and tibias,
depleted of red blood cells, and washed twice in phosphate
buffered saline (PBS). Cells were resuspended in a DC
medium consisting of RPMI 1640 supplemented with 10%
heat-inactivated fetal calf serum (FCS) (Gibco, NY, USA),
10 ng/mL GM-CSF (R&D Systems, Minneapolis, MN,
USA), 10 ng/mL IL-4 (R&D Systems, Minneapolis, MN,
USA), and 50 mM 2-mercaptoethanol, 100 IU/mL peni-
cillin, and 100 µg/mL streptomycin and cultured (37˚C, 5%
CO2) in 6-well plates at 1×10
6 cells/3 mL/well. On day 3
and 5 of culture, floating cells were gently removed, and
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MATERIALS AND METHODSfresh mGM-CSF/mIL-4-containing medium was added.
On day 6, non-adherent cells and loosely adherent proli-
ferating BMDCs aggregates were collected.
DCs co-culture was performed with three types of RM-1
cells (Ad-4-1BBL-tranduced RM-1 cells, Ad-eGFP-tran-
duced RM-1 cells, and normal RM-1 cells control) as sti-
mulator cells and DCs as responder cells. Stimulator cells
were incubated with Mitomycin C (MMC) at 50 ng/mL at
37˚C for 30 min and then washed with PBS twice. DCs
were plated in 24-well round-bottomed culture plate
(Costar, Union, CA, USA) at 4×10
5 cells per well. Then,
2×10
5 stimulators were added and co-cultured with res-
ponders after additional 48 h in a complete RPMI-1640
medium with 10 ng/mL GM-CSF and 10 ng/mL IL-4.
Surface marker analysis of DCs
For phenotypic analyses by flow cytometry, DCs were
stained for 30 min on ice with FITC- or PE-labeled mono-
clonal antibodies specific for CD11c, CD80, and CD86
(BD Pharmingen, San Diego, CA, USA), after washed
three times in PBS, the cells were analyzed by flow cyto-
metry. Isotype-matched monoclonal antibodies were used
as controls.
Cytokine production by DCs
For cytokine assays, co-culture supernatants were har-
vested and used for enzyme-linked immunosorbent assay
(ELISA). A mouse IL-6 Quantikine ELISA Kit (R&D
Systems, Minneapolis, MN, USA) and a mouse IL-12
Quantikine ELISA Kit (R&D Systems) were used to
detect IL-6 and IL-12, respectively, following the manu-
acturer’s instructions.
Statistical analysis
SPSS 13.0 (SPSS Inc, Chicago, IL, USA) was used for data
variation analysis. p values less than 0.05 were considered
statistically significant.
Identifying recombiant Ad-4-1BBL
The pAdTrack-CMV-4-1BBL containing full-length 4-
1BBL cDNA was detected by BglII and HindIII. Two
specific bands represented the pAdTrack-CMV shuttle
vector and 4-1BBL (Fig. 1). Then, the resultant pAdTrack-
CMV-4-1BBL was linearized with pmeI and cotransform-
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RESULTS
Fig. 2.Analysis of pAd-m4-1BBL by PacI. 1, 2 and 3, pAd-m4-1BBL digested with
PacI; M. λ /HindIII DNA Marker.
Fig. 1. Identification of pAdTrack-CMV-4-1BBL by restriction endonucleases
digestion. M. λ -EcoT14 DNA Marker; 1, pAdTrack-CMV digested with Bgl II; 2
and 3, pAdTrack-CMV-m4-1BBL digested with Bgl II/Hind III.
Fig. 3.Detection of 4-1BBL mRNA by RT-PCR. RM-1 cells were transfected with
pAd-4-1BBL. Total RNA was extracted, and 4-1BBL mRNA was detected by
RT-PCR. (A) M, DL 2000 DNA marker; 1, RM-1 cells transfected with pAd-4-
1BBL; 2, RM-1 cells. (B)  β-actin was used as reference. mRNA, messenger
ribonucleic acid, RT-PCR, reverse transcription polgmerase chain reaction.
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Bed with pAdEasy-1 backbone vector into competent
BJ5183. Recombinants were screened by restriction endo-
nuclease digestion with PacI (Fig. 2).
4-1BBL mRNA expression in Ad-4-1BBL-transfected 
RM-1 cells 
RM-1 cells were infected with recombinant adenovirus for
48 hours. Total RNA was extracted to perform RT-PCR.
A 483bp band amplified by 4-1BBL primers was presented
in cells infected with Ad-4-1BBL, but not in cells infected
with Ad-eGFP (Fig. 3A). β-actin was detected in all samples
(Fig. 3B).
4-1BBL protein expression in Ad-4-1BBL-transfected 
RM-1 cells 
RM-1 cells were infected with recombinant adenovirus for
48 hours. Cell protein was extracted to perform Western
blot analysis. Western blot analysis showed the 4-1BBL
protein expressed in cells infected with Ad-4-1BBL, but
nothing in the control cells (Fig. 4). β-actin protein were
detected in all samples.
Phenotype analysis of co-cultured DCs
To determine whether mouse 4-1BBL recombinant adeno-
virus effected co-stimulatory molecules on DCs, bone
marrow-derived DCs co-cultured with RM-1 cells infected
with Ad-4-1BBL, Ad-eGFP or uninfected, were analyzed
after costaining for CD11c and CD80, CD86 (Fig. 5). The
results indicate that DCs co-cultured with RM-1 cells in-
fected with Ad-4-1BBL specifically expressed high levels
of CD80 and CD86.
Cytokine production by DCs
To determine the mechanism of affection of DCs induced
by 4-1BB/4-1BBL costimulation, we analyzed cytokine
production by BMDC and RM-1 cells. Bone marrow-
derived DCs co-cultured with RM-1 cells infected with
Ad-4-1BBL, Ad-eGFP or uninfected. After 48 h, the culture
supernatants were harvested and analyzed for the produc-
tion of IL-6 and IL-12 by ELISA. The level of IL-6/IL-12
in Ad-4-1BBL-treated supernatant was more than the other
two groups. (Fig. 6).
DCs are one of the most potent APCs for the induction of
antitumor immune responses currently known and have
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DISCUSSION
Fig. 4. Detection of 4-1BBL protein by Western blot. Total cell lysates were
harvested and presence of 4-1BBL protein was detected by anti-4-1BBL
polyclonal antibody. A specific band was identified in RM-1 cells transfected
with Ad-4-1BBL but not in none-transfected RM-1 cells. β-actin was used as
reference.
Fig. 5. Activation of DCs by 4-1BBL. Bone-marrow-derived DCs from C57BL/6
mice were co-cultured with non-transfected, Ad-eGFP-transfected or Ad-4-
1BBL-transfected RM-1 cells. Flow cytometry showed expression of CD80,
CD86 molecules was significantly increased 4-1BBL. The experiment was
repeated three with representative data shown. DCs, dendritic cells.
Fig. 6. Ad-4-1BBL-transfected RM-1 cells induce IL-6/IL-12 production by DCs.
DCs were co-cultured with Ad-eGFP-transfected, Ad-4-1BBL-transfected or
none-transfected RM-1 cells. Cell-free supernatants were collected at 48 h and
IL-6/IL-12 were measured by Elisa. (A) The level of IL-6 in DC/Ad-4-1BBL group
was more than that in DC and DC/Ad-eGFP group,  *p< 0.05. (B) The production
of IL-12  in DC/Ad-4-1BBL group was higher than that in DC and DC/Ad-eGFP
group, *p< 0.05. Data are expressed as mean ±SD. Similar results were obtain-
ed from three independent experiments. IL, interleukin; SD, standard deviation.
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Bbeen recognized as potentially important tools for cancer
vaccine strategies.
1 One of the important elements of DCs
function is the level of their maturation. The mature DCs
expressed 4-1BBL, with which 4-1BB interaction could
enhance the maturation of DCs and the activation of T
cells.
10 In this study, we used replication-deficient adeno-
virus to generated a recombinant adenovirus encoding 4-
1BBL (Figs. 1 and 2), because of the adenovirus is the
most efficient for gene transfer. We confirmed the expres-
sion of 4-1BBL in Ad-4-1BBL-transfected RM-1 cells
(Figs. 3 and 4), and demonstrated that 4-1BBL induced
pro-found changes in DC immune properties. DCs co-
cultured with Ad-4-1BBL-transfected RM-1 cells pro-
duced higher levels of IL-6/IL-12 than Ad-eGFP-trans-
fected and non-transfected RM-1 cells; the difference was
significant (p < 0.01) (Fig. 6). Ad-4-1BBL-transfected
RM-1 cells induced CD80/ CD86 up-regulation on DCs
(Fig. 5).
In this study, we further confirmed the expression of 4-
1BB on DC, and the 4-1BB molecules expressed on DC
were functional to active DC. Our results were consistent
with previous reports,
9 which showed that the 4-1BB/4-
1BBL interaction could induce DC activation by DC-DC
interaction. Recent reports have shown that DC play a
important role in eliciting anti-tumor immunity.
11,12 How-
ever, mechanisms for the DC-tumor interaction remain
largely unknown. Our present results suggest a possibility
that 4-1BB molecules expressed on DC may be involved
in tumor surveillance by DC. It should be also noted that
the 4-1BBL-mediated activation of DC might be involved
in the anti-tumor effect of 4-1BBL gene transfer. This mo-
dality has been thought to exert the immunopotentiating
effect by directly co-stimulating T cells. However, our
results suggested that DC activation by this modality might
play a rather critical role.
Recent studies using Ad-4-1BBL detect the change of
immunoactivity of dendritic cells. However, the mecha-
nisms for the DC-tumor interaction need to further investi-
gation.
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